Teva Urges High Court To Review Disputed Labeling Theory
By Sindhu Sundar ( April 13, 2015, 4:51 PM EDT) -- Teva Pharmaceuticals USA Inc. has urged the U.S. Supreme Court to review the controversial "failure to update" theory in which plaintiffs generally claim that generic-drug makers should be held liable for not updating their warning labels to match newer labels approved by regulators. ...
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.